| 2025-11-05 |
详情>>
股本变动：
变动后总股本12027.31万股
变动原因 ▼▲
- 原因：
- 20250630-20250930
普通股回购
限制性股票单位归属
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益16.47美元,归母净利润19.84亿美元,同比去年增长4.42%
|
| 2025-11-05 |
财报披露：
美东时间 2025-11-05 盘前发布财报
|
| 2025-11-01 |
详情>>
内部人交易：
Smith Gordon股份增加765.00股
|
| 2025-07-30 |
详情>>
业绩披露：
2025年中报每股收益14.83美元,归母净利润17.89亿美元,同比去年增长25.99%
|
| 2025-04-30 |
详情>>
业绩披露：
2025年一季报每股收益10.31美元,归母净利润12.44亿美元,同比去年增长67.88%
|
| 2025-03-07 |
股东大会：
将于2025-04-17召开股东大会
会议内容 ▼▲
- 1.Elect the eleven director nominees named in the proxy statement.
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2025.
3.Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4.Consider any other business properly brought before the meeting.
|
| 2025-02-20 |
详情>>
业绩披露：
2024年年报每股收益10.01美元,归母净利润12.07亿美元,同比去年增长-51.51%
|
| 2025-02-20 |
详情>>
业绩披露：
2022年年报每股收益22.20美元,归母净利润28.06亿美元,同比去年增长-4.33%
|
| 2024-10-30 |
详情>>
业绩披露：
2024年三季报(累计)每股收益15.76美元,归母净利润19.00亿美元,同比去年增长-37.29%
|
| 2024-07-31 |
详情>>
业绩披露：
2024年中报每股收益11.76美元,归母净利润14.20亿美元,同比去年增长-35.4%
|
| 2024-07-31 |
详情>>
业绩披露：
2023年中报每股收益17.62美元,归母净利润21.98亿美元,同比去年增长35.18%
|
| 2024-04-24 |
详情>>
业绩披露：
2024年一季报每股收益6.13美元,归母净利润7.41亿美元,同比去年增长-40.19%
|
| 2024-03-08 |
股东大会：
将于2024-04-18召开股东大会
会议内容 ▼▲
- 1.Elect the eleven (11) director nominees named in the proxy statement.
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2024.
3.Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4.Approve amendment to the Company’s Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted by Delaware law.
5.Approve amendment to the Company’s Restated Certificate of Incorporation to eliminate supermajority voting requirement in connection with certain transactions.
6.Consider and vote upon the stockholder proposal set forth in this proxy statement, if properly presented at the meeting.
7.Consider any other business properly brought before the meeting.
|
| 2024-02-15 |
详情>>
业绩披露：
2023年年报每股收益20.09美元,归母净利润24.89亿美元,同比去年增长-11.3%
|
| 2023-11-01 |
详情>>
业绩披露：
2023年三季报(累计)每股收益24.37美元,归母净利润30.30亿美元,同比去年增长7.41%
|
| 2023-03-08 |
股东大会：
将于2023-04-20召开股东大会
会议内容 ▼▲
- 1.Elect the twelve (12) director nominees named in the proxy statement.
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2023.
3.Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4.Non-binding advisory vote regarding the frequency of the voting with respect to the compensation of the Company’s Named Executive Officers.
5.Consider any other business properly brought before the meeting.
|
| 2022-03-09 |
股东大会：
将于2022-04-21召开股东大会
会议内容 ▼▲
- 1.Elect the thirteen (13) director nominees named in the proxy statement.
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2022.
3.Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4.Consider any other business properly brought before the meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-10 |
股东大会：
将于2021-04-22召开股东大会
会议内容 ▼▲
- 1.Elect the thirteen (13) director nominees named in the proxy statement.
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2021.
3.Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4.Consider any other business properly brought before the meeting.
|
| 2020-04-23 |
除权日：
美东时间 2020-06-29 每股派息0.63美元
|
| 2020-03-04 |
股东大会：
将于2020-04-23召开股东大会
会议内容 ▼▲
- 1.Elect the twelve (12) director nominees named in the proxy statement.
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2020.
3.Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4.Consider any other business properly brought before the meeting.
|
| 2020-02-20 |
除权日：
美东时间 2020-03-30 每股派息0.63美元
|
| 2019-10-24 |
除权日：
美东时间 2019-12-30 每股派息0.55美元
|
| 2019-08-22 |
除权日：
美东时间 2019-09-27 每股派息0.55美元
|
| 2019-04-18 |
除权日：
美东时间 2019-06-27 每股派息0.55美元
|
| 2019-03-06 |
股东大会：
将于2019-04-18召开股东大会
会议内容 ▼▲
- 1.Elect the ten (10) director nominees named in the proxy statement.
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2019.
3.Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4.Approve the Amended and Restated Humana Inc. Stock Incentive Plan.
5.Consider any other business properly brought before the meeting.
|
| 2018-04-19 |
除权日：
美东时间 2018-06-28 每股派息0.50美元
|
| 2018-03-07 |
股东大会：
将于2018-04-19召开股东大会
会议内容 ▼▲
- 1. Elect the twelve (12) director nominees named in the proxy statement.
2. Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2018.
3. Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4. Consider any other business properly brought before the meeting.
|
| 2018-02-06 |
除权日：
美东时间 2018-03-28 每股派息0.50美元
|
| 2017-11-02 |
除权日：
美东时间 2017-12-28 每股派息0.40美元
|
| 2017-08-17 |
除权日：
美东时间 2017-09-28 每股派息0.40美元
|
| 2017-04-20 |
除权日：
美东时间 2017-06-28 每股派息0.40美元
|
| 2017-03-08 |
股东大会：
将于2017-04-20召开股东大会
会议内容 ▼▲
- 1. Elect the ten (10) director nominees named in the proxy statement.
2. Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2017.
3. Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4. on-binding, advisory vote regarding the frequency of the voting with respect to the compensation of the Company’s Named Executive Officers.
5. Consider and vote upon the stockholder proposal set forth in this proxy statement, if presented.
6. Consider any other business properly brought before the meeting.
|
| 2017-02-15 |
除权日：
美东时间 2017-03-29 每股派息0.40美元
|
| 2016-10-26 |
除权日：
美东时间 2017-01-10 每股派息0.29美元
|
| 2016-10-12 |
复牌提示：
2016-10-12 10:09:27 停牌，复牌日期 2016-10-12 10:29:30
|
| 2016-08-25 |
除权日：
美东时间 2016-10-11 每股派息0.29美元
|
| 2016-04-21 |
除权日：
美东时间 2016-06-28 每股派息0.29美元
|
| 2016-03-09 |
股东大会：
将于2016-04-21召开股东大会
会议内容 ▼▲
- 1.Elect the ten (10) director nominees named in the proxy statement.
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2016.
3.Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4.Consider any other business properly brought before the meeting.
|
| 2016-02-18 |
除权日：
美东时间 2016-03-29 每股派息0.29美元
|
| 2015-10-29 |
除权日：
美东时间 2015-12-28 每股派息0.29美元
|
| 2015-08-28 |
股东大会：
将于2015-10-19召开股东大会
会议内容 ▼▲
- 1.to consider and vote on a proposal to adopt the Agreement and Plan of Merger, dated as of July 2, 2015, as it may be amended from time to time (which is referred to in this notice as the merger agreement), among Aetna Inc., a Pennsylvania corporation, Echo Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Aetna, Echo Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Aetna, and Humana, pursuant to which Echo Merger Sub, Inc. will be merged with and into Humana, and Humana will continue as the surviving corporation and a wholly owned subsidiary of Aetna, and, immediately thereafter, Humana will be merged with and into Echo Merger Sub, LLC, and Echo Merger Sub, LLC will continue as the surviving company and a wholly owned subsidiary of Aetna (a copy of the merger agreement is attached as Annex A to the accompanying joint proxy statement/prospectus);
2.to consider and vote on a proposal to approve the adjournment from time to time of the Humana special meeting if necessary to solicit additional proxies if there are not sufficient votes to adopt the merger agreement at the time of the Humana special meeting or any adjournment or postponement thereof;
3.to consider and vote on a proposal to approve, on an advisory (non-binding) basis, compensation that will or may be paid or provided by Humana to its named executive officers in connection with the merger.
|
| 2015-08-27 |
除权日：
美东时间 2015-09-28 每股派息0.29美元
|
| 2015-04-17 |
除权日：
美东时间 2015-06-26 每股派息0.29美元
|
| 2015-02-18 |
除权日：
美东时间 2015-03-27 每股派息0.28美元
|
| 2014-10-31 |
除权日：
美东时间 2014-12-29 每股派息0.28美元
|
| 2014-08-27 |
除权日：
美东时间 2014-09-26 每股派息0.28美元
|
| 2014-04-30 |
除权日：
美东时间 2014-06-26 每股派息0.28美元
|
| 2014-02-19 |
除权日：
美东时间 2014-03-27 每股派息0.27美元
|
| 2013-10-30 |
除权日：
美东时间 2013-12-27 每股派息0.27美元
|
| 2013-08-22 |
除权日：
美东时间 2013-09-26 每股派息0.27美元
|
| 2013-04-25 |
除权日：
美东时间 2013-06-26 每股派息0.27美元
|
| 2013-02-27 |
除权日：
美东时间 2013-03-26 每股派息0.26美元
|
| 2012-10-18 |
除权日：
美东时间 2012-12-27 每股派息0.26美元
|
| 2012-08-24 |
除权日：
美东时间 2012-09-26 每股派息0.26美元
|
| 2012-04-26 |
除权日：
美东时间 2012-06-27 每股派息0.26美元
|
| 2012-02-24 |
除权日：
美东时间 2012-03-28 每股派息0.25美元
|
| 2011-10-24 |
除权日：
美东时间 2011-12-28 每股派息0.25美元
|
| 2011-08-17 |
除权日：
美东时间 2011-09-28 每股派息0.25美元
|
| 2011-04-26 |
除权日：
美东时间 2011-06-28 每股派息0.25美元
|